Overview

Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics

Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
This study will test the effectiveness of two different treatments for children and adolescents who have gained weight on their antipsychotic medications.
Phase:
Phase 4
Details
Lead Sponsor:
Johns Hopkins University
Collaborators:
National Institute of Mental Health (NIMH)
The Zucker Hillside Hospital
University of Maryland
University of Maryland, College Park
University of North Carolina, Chapel Hill
Treatments:
Antipsychotic Agents
Aripiprazole
Asenapine
Fluoxetine
Iloperidone
Lurasidone Hydrochloride
Metformin
Olanzapine
Paliperidone Palmitate
Perphenazine
Quetiapine Fumarate
Risperidone
Ziprasidone